Data / Form D filings / Modulate Bio Inc.
Modulate Bio Inc.: Form D filings
Modulate Bio Inc., a biotechnology company in Allston, MA, filed 3 Form D notices with the SEC between 2024 and 2026. The latest, on April 7, 2026, reports $785,320 sold of a $1 million offering to 10 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- PAGLIUCA HARVARD LIFE LAB 127 WESTERN AVE, Allston, MA, 02134
- Phone
- (603) 568-8753
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2026915
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 7, 2026 | Amendment | $1,000,000 | $785,320 | $214,680 | 10 | Feb 11, 2024 | sec.gov |
| Jun 12, 2025 | Amendment | $1,000,000 | $660,000 | $340,000 | 8 | May 31, 2024 | sec.gov |
| Jun 13, 2024 | New notice | Indefinite | $200,000 | 2 | May 31, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Andrew Thomson | Executive Officer, Director, Promoter | |
| Dario Doller | Executive Officer, Director, Promoter | |
| Kevin Hodgetts | Promoter |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Apr 6, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Modulate Bio Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.